Peripheral T-Cell Lymphomas-Not Otherwise Specified: A Shrinking Entity? |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Emerging Therapeutic Options in Acute Lymphoblastic Leukemia |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Advances in Acute Myeloid Leukemia (AML) Management: Focus on Secondary AML and Older Patients with AML |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Myeloproliferative Neoplasms: Emerging Treatment Options for Myelofibrosis |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Evolving Concepts in the Diagnosis and Staging of Multiple Myeloma |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Bonanza of New Treatment Regimens for Multiple Myeloma: What is Right for My Patient? |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Smoldering Multiple Myeloma: What is the Threshold to Start Treatment? |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Interactive Online Case Studies: Lymphoma - Case 1 |
0.25 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Interactive Online Case Studies: Lymphoma - Case 3 |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Interactive Online Case Studies: Plasma Cell Neoplasms - Case 1 |
0.25 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Interactive Online Case Studies: Plasma Cell Neoplasms - Case 2 |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Interactive Online Case Studies: Plasma Cell Neoplasms - Case 3 |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Interactive Online Case Studies: Leukemia, Myelodysplastic Syndromes, and Myeloproliferative Disorders - Case 1 |
0.25 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Interactive Online Case Studies: Leukemia, Myelodysplastic Syndromes, and Myeloproliferative Disorders - Case 2 |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Gastric Cancer |
1.00 |
11/05/2020 - 12:00am to 11/05/2021 - 12:00am |